New York, NY, United States of America

Nicholas Tatonetti

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nicholas Tatonetti

Introduction

Nicholas Tatonetti is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of drug safety through his innovative algorithms. With a total of 2 patents, Tatonetti's work focuses on enhancing the detection of adverse drug events.

Latest Patents

Tatonetti's latest patents include groundbreaking algorithms designed for signal detection to identify drug effects and interactions. These algorithms provide latent signal detection of adverse events by inferring the presence of adverse drug events from large observational databases maintained by organizations such as the FDA and WHO. Notably, these algorithms do not require explicit reporting of adverse events. Instead, they utilize more common secondary effects to infer the presence of these events. Machine learning techniques are employed in these algorithms to enhance their effectiveness.

Career Highlights

Nicholas Tatonetti is affiliated with Leland Stanford Junior University, where he continues to advance research in drug safety and signal detection. His work has garnered attention for its potential to improve patient safety and inform healthcare practices.

Collaborations

Tatonetti collaborates with notable colleagues, including Russ B Altman and Guy Haskin Fernald, contributing to a rich environment of innovation and research.

Conclusion

Nicholas Tatonetti's contributions to the field of drug safety through his innovative algorithms highlight the importance of technology in healthcare. His work not only enhances the detection of adverse drug events but also paves the way for safer medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…